US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 45.540
  • -0.500-1.09%
Close Aug 16 16:00 ET
  • 45.540
  • 0.0000.00%
Post 16:20 ET
1.71BMarket Cap-8877P/E (TTM)

About Keros Therapeutics Company

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Company Profile

SymbolKROS
Company NameKeros Therapeutics
Listing DateApr 8, 2020
Issue Price16.00
Founded2015
CEODr. Jasbir Seehra, PhD
MarketNASDAQ
Employees136
Fiscal Year Ends12-31
Address1050 Waltham Street,Suite 302
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-617-314-6297
Websitehttp://www.kerostx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jasbir Seehra, PhD
  • Chief Executive Officer and Chairman of the Board
  • 8.93M
  • Christopher Rovaldi
  • Chief Operating Officer and President
  • 4.69M
  • Keith Regnante
  • Chief Financial Officer and Principal Accounting Officer
  • 2.20M
  • Ran Nussbaum
  • Independent Director
  • 390.56K
  • Julius Knowles
  • Independent Director
  • 388.48K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 396.98K
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 409.37K
  • Nima Farzan
  • Independent Director
  • 388.48K
  • Dr. Alpna Seth, PhD
  • Independent Director
  • 1.02M
  • Tomer Kariv
  • Independent Director
  • 385.86K
  • Jean-Jacques Bienaime
  • Lead Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg